The US Innovation Engine: Why North America Still Leads the Antibody Charge
Despite the rapid growth in other regions, the United States remains the undisputed heavyweight champion of antibody innovation. It’s the sheer density of talent, capital, and world-class universities that makes it a unique environment for biological breakthroughs. In the US, the "bench-to-bedside" pipeline is shorter and faster than almost anywhere else, meaning new ideas become real...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek